Alternatives to ProteinQure

Clinical-stage precision medicine company using protein motion insights for drug discovery.

AI-driven drug discovery platform for rapid development of novel therapeutics.

AI-powered drug discovery and development platform for biologics.

Develops and manufactures biologics for therapeutic applications.

AI-guided drug discovery platform for tissue-targeted medicines.

AI-powered biotechnology company developing RNA therapeutics for genetic diseases.

AI-powered drug discovery platform for GPCR targets, accelerating development and reducing risk.

Leveraging quantum mechanics for accelerated molecular simulations in drug discovery.

Quantum software company enabling breakthroughs in chemistry, materials science, and life sciences.

Leveraging the adaptive immune system to diagnose and treat disease.

Developing engineered biologics to harness the immune system for disease treatment.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

AI-powered platform for personalized cell therapy development and manufacturing.

AI platform for drug discovery and development, optimizing targets, compounds, and combination therapies.

AI-powered platform for antibody discovery and development to create new medicines.

A global oncology company developing and commercializing innovative cancer treatments.

Computational protein design company creating novel enzymes and proteins using AI and physics-based modeling.

AI platform for drug discovery and development, accelerating research with advanced computational tools.

A clinical-stage oncology company developing DNA interference (DNAi) based cancer therapies.

A precision biotechnology company developing a blood-based platform for early cancer detection and treatment.

Clinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases.

Biotechnology company developing novel immunotherapies for cancer.

Leap Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel targeted and immuno-oncology therapies.

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

Biopharmaceutical company developing novel cancer therapies using targeted protein degradation.

Clinical-stage biotechnology company developing allogeneic gamma delta T cell therapies for cancer and autoimmune diseases.

Developing novel radiopharmaceuticals for targeted cancer treatment using advanced molecular imaging and therapy.

Alto Neuroscience is a clinical-stage biopharmaceutical company developing precision psychiatry medicines for mental health conditions.

AI-powered spatial biology platform for precision medicine and drug development.

Develops novel therapeutic antibodies for oncology and autoimmune diseases.

AI-powered platform for profiling cancer biomarkers from digitized biopsy images.

Lunit is a medical AI company developing AI-powered solutions for cancer diagnostics and therapeutics.

Clinical-stage biopharma developing precisely designed cancer therapeutics using a proprietary cell-free protein synthesis platform.

A clinical-stage genome editing company developing novel therapies using CRISPR/Cas9 technology for severe diseases.

Biopharmaceutical company developing mRNA-based vaccines and therapeutics for infectious diseases and cancer.

Personalizing cancer care through a novel, physics-informed approach to predict tumor response to therapy.

Biotechnology company specializing in antibody discovery and development with integrated 'Idea to IND' solutions.

Precision oncology company developing cancer therapies guided by proprietary functional genomics.

Personalized medicine startup focused on accurate cancer treatment through advanced diagnostics and functional drug sensitivity testing.

Biotech company using AI and deep RNA analysis to predict cancer treatment response.

AI-powered blood test for early cancer detection and subtyping.

AI platform for accelerating novel peptide therapeutic discovery and development.

AI-powered breast cancer detection and risk assessment solutions.

A global biotechnology company discovering, developing, manufacturing, and delivering innovative human therapeutics.

Leveraging proteomic pattern analysis to personalize cancer treatment and improve patient outcomes.

Developing novel diagnostics to predict patient response to immunotherapy.

Developing Quantum ADCs against the tumor microenvironment for innovative cancer therapies.

Cradle Bio B.V. is a Dutch, Swiss biotechnology company that develops software using machine learning for protein engineering. It was founded in 2021 and is base

BioCorteX is a tech bio company developing precision medicine solutions using AI-powered in-silico simulations to understand drug-bacteria interactions and personalize treatments.

Revolutionizing prenatal testing with non-invasive fetal DNA analysis from maternal blood.

Developing a new histotripsy therapeutic platform for cancer treatment.

Integrates scientific big data with patient medical records for personalized disease models and AI-driven insights.

Transforming healthcare by turning scientific fiction into scientific facts.

Phenomics-driven AI company translating disease biology into precision medicine discoveries.

OncoDecipher uses silent mutations in cancer genomes to predict cancer type and survival probability.

Biopharmaceutical company developing novel therapeutics for cancer and other diseases using chemoproteomics and covalent chemistry.

Synthace provides a no-code cloud platform for life sciences R&D, enabling scientists to automate experimentation and insight sharing.

Computational oncology service analyzing tumor RNA-seq for origin, subtype, druggable alterations, and immune profile.

Intero Biosystems develops human intestinal organoid platforms for drug discovery, aiming to improve preclinical testing and reduce animal reliance.